Effect of Heparin Reversal by Protamine Sulfate on the Outcome of Thrombolysis in Acute Ischemic Stroke after Percutaneous Coronary Intervention.

The article focuses on three medical studies related to neurological and cardiovascular conditions in Egyptian patients. One study found that fatigue, anxiety, and depression symptoms were more prevalent in recently diagnosed multiple sclerosis (MS) patients before diagnosis compared to global and Egyptian population rates, suggesting these symptoms may warrant further investigation as prodromal risk factors. Another study assessed quality of life (QoL) and functionality in Egyptian patients with amyotrophic lateral sclerosis (ALS) during the COVID-19 pandemic, revealing significant correlations between QoL scores and factors such as age, gender, comorbidities, and disease onset type, with worsened QoL observed after COVID-19 infection. A third study evaluated the safety of intravenous thrombolysis (IVT) after heparin reversal by protamine sulfate in acute ischemic stroke (AIS) patients following percutaneous coronary intervention (PCI), concluding that IVT appears safe in selected patients, though caution is advised before generalizing these findings.